Cefotaxime is the most commonly used antibiotic for initial therapy of spontaneous bacterial peritonitis in cirrhosis. However, since the introduction of cefotaxime no study has been performed to investigate factors influencing prognosis in cirrhotic patients with this type of infection. In this stu
Marked improvement in the resolution of, and survival rates in, spontaneous bacterial peritonitis
β Scribed by Kazuyuki Suzuki; Yasuhiro Takikawa
- Book ID
- 106182451
- Publisher
- Springer Japan
- Year
- 2002
- Tongue
- English
- Weight
- 35 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In a recently published report, Rimola et al. compared Gudiol F. Aztreonam vs cefotaxime in the treatment of gramtwo different dosages of cefotaxime (CTX) in the treatnegative spontaneous bacterial peritonitis. HEPATOLOGY 1991;14: 91-98. ment of spontaneous bacterial peritonitis (SBP). 1 They 3. Cra
We investigated whether spontaneous bacterial peritonitis in cirrhosis is a recurrent process and attempted to identify possible predictors of recurrence in 75 consecutive cirrhotics who had recovered from a first episode of spontaneous bacterial peritonitis between January, 1981 and December, 1984
In order to evaluate the diagnostic accuracy of ascitic pH and lactate for early confirmation of spontaneous bacterial peritonitis (SBP), 109 consecutive patients with ascites were studied. The mean ascitic leukocyte [white blood cell (WBC)] and polymorphonuclear cell (PMN) counts, pH and lactate le